Key result
Echocardiography, particularly 2D and transesophageal echocardiography, plays a crucial role in the selection, intraprocedural guidance, and follow-up of patients undergoing percutaneous treatments for structural heart diseases.
This review highlights the critical role of 2D echocardiography (TTE, TEE, ICE) in the selection, guidance, and follow-up of patients undergoing various structural and electrophysiological percutaneous interventions.
Answers are grounded in this paper and cite their sources.
Supports echocardiography for selection, guidance, and follow-up in structural interventions; leaves open standardization across emerging percutaneous therapies.
Aortic stenosis and mitral regurgitation, patent foramen ovale, interatrial septal defect, atrial fibrillation and perivalvular leak, are now amenable to percutaneous treatment. These percutaneous procedures require the use of Transthoracic (TTE), Transesophageal (TEE) and/or Intracardiac echocardiography (ICE). This paper provides an overview of the different percutaneous interventions, trying to provide a systematic and comprehensive approach for selection, guidance and follow-up of patients undergoing these procedures, illustrating the key role of 2D echocardiography.
No takes yet. Share an insight, caveat, or question.
Contaldi et al. (2012) conducted a review in Structural heart diseases (Aortic stenosis, Mitral regurgitation, PFO, ASD, Atrial fibrillation, Paravalvular leaks). Percutaneous cardiovascular interventions and echocardiography guidance was evaluated. Echocardiography, particularly 2D and transesophageal echocardiography, plays a crucial role in the selection, intraprocedural guidance, and follow-up of patients undergoing percutaneous treatments for structural heart diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: